| Literature DB >> 35509746 |
Ana K Gómez-Gutiérrez1, Areli A Flores-Camargo1, Andrea Casillas Fikentscher1, Eder Luna-Ceron1.
Abstract
Varicella-zoster virus is a pathogenic virus that can present itself as a primary infection or secondary infection, also known as herpes zoster. Recently, there has been a re-emergence of this vaccine-preventable disease due to gaps in vaccination. Primary varicella in immunocompetent adults is highly uncommon, and it could result in severe complications within this population. Given this delicate scenario, family physicians should be well trained to recognize the characteristic cutaneous lesions of varicella and dictate adequate management for these patients to obtain the best possible outcome and prevent life-threatening complications. We present the case of a 43-year-old immunocompetent woman with the onset of a generalized pruritic dermatosis characterized primarily by the presence of macules, vesicles, and crusts. The patients' lesions were compatible with primary varicella, and serological studies confirmed the diagnosis. Given the absence of acute complications in this individual, supportive treatment and close follow-up were the therapeutic modalities. This article focuses on the educational discussion of the primary differential diagnosis, evaluation for possible complications, and management of this uncommon clinical scenario. We also reinforce the importance of immunization in preventing re-emergent diseases as a critical element within primary care management.Entities:
Keywords: adult-onset; primary care medicine; vaccine-preventable disease; varicella vaccine; varicella zoster virus infection; herpes zoster
Year: 2022 PMID: 35509746 PMCID: PMC9057244 DOI: 10.7759/cureus.23732
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Representative images of the dermatoses of the patient and her husband
(a) Rash composed of vesicles with erythematous bases, papules, and crusts within the dorsal region. (b) Localized rash characterized by the presence of small blisters and crusts. (c) Representation of the main dermatomes within the superior body segment.
Image credit: The author, Eder Luna-Ceron, drew Figure 1c with the help of the BioRender platform.
Laboratory results of the patient on the day of the examination
Results are expressed in values, and normal or abnormal results are noted in parenthesis.
HIV: Human immunodeficiency virus; Ig: Immunoglobulin; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; hs-CRP: High-sensitivity C-reactive protein; ISR: immune status ratio.
| Parameters | Results |
| HIV rapid testing | Negative |
| Varicella-zoster IgG antibody | 31.2 ISR (Negative) |
| Varicella-zoster IgM antibody | 5.2 ISR (Positive) |
| AST | 22 U/L (Normal) |
| ALT | 23 U/L (Normal) |
| hs-CRP | 0.7 mg/L (Normal) |
| Procalcitonin | 0.03 ng/mL (Normal) |
Main differential diagnoses representing dermatoses consisting of pruritic vesicles in the adult population
HSV: Herpes simplex virus; VZV: Varicella-zoster virus.
| Characteristics | Primary Varicella | Herpes Zoster | Dermatitis Herpetiformis | HSV | Dyshidrotic Eczema | Contact Dermatitis |
| Epidemiology | Mainly during childhood, most commonly in unvaccinated children | Mainly in older adults and patients with immunodeficiency | Adolescent and adults (15-40 years old), more frequent in males | Children and adults | Young adults | Children and adults |
| Physiopathology | Primary infection | Reactivation and multiplication of latent VZV that persisted within trigeminal and dorsal root ganglia following varicella | Genetic predisposition, autoimmune, associated with gluten sensitivity and celiac disease | Reactivation triggered by stress, immunodeficiency, and trauma | Unknown- multifactorial | Type IV hypersensitivity reaction (T-cell mediated) |
| Distribution | It begins on the face and scalp and progresses to spread to the trunk and the rest of the body | Unilateral following dermatomal distribution, disseminated in immunocompromised patients | Bilateral and symmetrical; can manifest in elbows, dorsal forearms, knees, buttocks, back, shoulders, and scalp without mucosal involvement | Oral/labial, vermilion border, genitals, and buttocks; disseminated lesions in patients with immunodeficiency | Hands and lateral aspect of fingers | Linear distribution localized where contact with allergen took place |
| Lesions | Scattered, they progress from rose-colored macules to papules, vesicles, pustules, and crust; rashes in all different stages | Erythematous maculopapular rash and vesicles within the affected dermatome | Grouped vesicles and papules, tense and with herpetiform appearance; followed by erosions, excoriations, and post-inflammatory hyperpigmentation, but most commonly heals without scarring | Painful vesicles that progress to a crust within a week | Symmetric eruption of vesicles may coalesce into bullae; usually persist for several weeks until desiccation and desquamation | Intensely pruritic dermatitis, characterized by erythema and vesicles in more severe cases |
| Symptomatology | Fever, malaise, anorexia, and pruritus | Pain in the distribution of the dermatome; pain is excruciating burning, tingling, itching, or stabbing | Intensely pruritic | Prodrome of pain, tingling, and burning 24 hours prior to rash development | Prodromal itching followed by abrupt onset of intensely pruritic vesicles | Pruritic and burning lesions |
Differences between herpes zoster and primary varicella
VZV: Varicella-zoster virus.
| Characteristics | Herpes Zoster | Primary Varicella |
| Epidemiology | Mainly older adults and immunocompromised patients | Mainly during childhood, most commonly in unvaccinated children |
| Physiopathology | Reactivation and multiplication of latent VZV that persisted within neurons following varicella | Primary infection |
| Distribution | Unilateral dermatomal pain and rash result from reactivation and multiplication of latent VZV that persisted within neurons following varicella | It begins on the face and scalp and progresses to spread to the trunk and the rest of the body. |
| Lesions | Erythematous maculopapular rash and vesicles within the affected dermatome | Scattered, they progress from rose-colored macules to papules, vesicles, pustules, and crusts. Rashes in all different stages. |
| Symptomatology | Pain in the distribution of the dermatome. Pain is excruciating burning, tingling, itching, or stabbing. | Fever, malaise, anorexia, and pruritus |
| Complications | Postherpetic neuralgia, bacterial superinfection, zoster gangrenous, pneumonitis, hepatitis, esophagitis, gastritis, pericarditis, cystitis, arthritis, meningoencephalitis, transverse myelitis, deafness, and cranial nerve palsies | Pneumonia, hepatitis, encephalitis, hemorrhagic complications (mild febrile purpura to severe purpura fulminans), invasive infections, arteritis, and myocarditis |
| Histopathology | Intranuclear inclusion bodies and multinucleated giant cell | Intranuclear inclusion bodies and multinucleated giant cell |
| Prophylaxis | Vaccination | Vaccination |